Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4733550

CNC1CCC(NCc2cc(-c3ccnc(C)c3)ccc2OC)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 5/20 0.40
PSEN2 P49810 5/20 0.40
APH1B Q8WW43 5/20 0.40
NCSTN Q92542 5/20 0.40
APH1A Q96BI3 5/20 0.40
PSENEN Q9NZ42 5/20 0.40
CYP2D6 P10635 2/20 0.40
CYP3A4 P08684 1/20 0.40
TACR1 P25103 3/20 0.40
WNT3A P56704 1/20 0.38
MTOR P42345 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36
ADORA1 P30542 1/20 0.36
WDR5 P61964 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ABL1 P00519 1/20 0.36
DYRK1A Q13627 1/20 0.36
PDE4B Q07343 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4731937 0.90 TACR1 (0.39) CYP3A4TACR1MTORADORA2AADORA2B
Trifluoroacetic Acid SCHEMBL4733545 0.89 KDM4E (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
Hydrochloric Acid SCHEMBL4731741 0.89 TACR1 (0.43) TACR1MTORMEN1KMT2ADYRK1A
Trifluoroacetic Acid SCHEMBL4730619 0.89 GRIN2B (0.38) CYP2D6TACR1ADORA2AADORA2BADORA1
Trifluoroacetic Acid SCHEMBL4732317 0.85 PPARA (0.46) TACR1ADORA2AADORA2BADORA1MEN1
Trifluoroacetic Acid SCHEMBL4733937 0.84 PPARD (0.39) CYP2D6TACR1ADORA2AADORA2BADORA1
Trifluoroacetic Acid SCHEMBL4732776 0.84 PDE4A (0.40) TACR1ADORA2AADORA2BADORA1MEN1
Trifluoroacetic Acid SCHEMBL4732362 0.84 DYRK1A (0.39) TACR1MTORABL1DYRK1APDE4B
SCHEMBL4732455 0.83 WNT3A (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4732454 0.83 MAPK14 (0.43) TACR1WNT3AMTORWDR5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273747-B2 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin CURIS, INC. (US) 2012-09-25 US disclosed
US-20080193423-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080194637-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin CURIS, INC. (US) 2008-07-31 US disclosed
WO-2008057468-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
WO-2008057469-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION WYETH (US) 2008-05-15 WO disclosed
WO-2008057497-A2 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
US-20080058521-A1 Processes for the preparation of compounds WYETH (US) 2008-03-06 US disclosed
WO-2007089669-A2 PROCESSES FOR THE PREPARATION OF COMPOUNDS WHICH MODULATE CELL PROLIFERATION WYETH (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193423-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO PSEN1 2597/4885PSEN2 2825/4885APH1B 2789/4885
US-20080058521-A1 Processes for the preparation of compounds MKI67, MCL1, DCX PSEN1 2605/4885PSEN2 2191/4885APH1B 904/4885
US-20080194637-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO PSEN1 2597/4885PSEN2 2825/4885APH1B 2789/4885
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin SHH, GLI1, SMO PSEN1 58/4885PSEN2 155/4885APH1B 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.